Scandinavian ChemoTech AB Series B (CMOTEC-B) — Free Cash Flow Generation Index
Latest as of December 2020:
0.86x
Scandinavian ChemoTech AB Series B (CMOTEC-B) has a Free Cash Flow Generation Index of 0.86x as of December 2020. Free cash flow of Skr177.00K represents 1% of operating cash flow (Skr207.00K). Explore Scandinavian ChemoTech AB Series B (CMOTEC-B) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
0.86x
Free Cash Flow / Operating CF
Free Cash Flow
Skr177.00K
SEK
Operating Cash Flow
Skr207.00K
SEK
Capital Expenditures
Skr30.00K
SEK
Annual Free Cash Flow Generation for Scandinavian ChemoTech AB Series B (None–None)
Year-by-year Free Cash Flow Generation Index for Scandinavian ChemoTech AB Series B. Check Scandinavian ChemoTech AB Series B investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (SEK) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).